top of page
未命名設計-5.png

Alzheimer's disease new blood test p-Tau 217

Alzheimer's disease (AD) is the most common form of dementia. Brain changes may have already begun before obvious cognitive impairment appears.

 

The p-tau 217 blood test is a novel and highly accurate examination, with an accuracy rate of 96%, that can detect Alzheimer's disease early.

"Memory decline is not a part of aging—it's a warning sign."

Get Tested Early. Take Action Early.

The advantages are clear at a glance.

🔹 High Accuracy – 96%* accuracy rate; can distinguish Alzheimer's disease from other memory issues. 

🔹 Fast & Convenient – Simple test with rapid results  

🔹 Early Detection – Can identify changes before obvious symptoms appear  

🔹 Non-Invasive – Only requires a blood draw; no spinal tap or imaging needed  

🔹 Suitable for Anyone Concerned About Brain Health – Whether experiencing forgetfulness or with a family history

*Source: Published in JAMA Neurology, 2024 Mar 1;81(3):255-263.

Who Should Get Tested?

🔸 Individuals aged 40 and over.

🔸 Those with a family history of Alzheimer's disease.

🔸 People experiencing forgetfulness or cognitive changes.

🔸 Anyone concerned about brain health and interested in early prevention.

Q&A

1/ How is this different from a standard memory test?

Traditional memory assessments only evaluate performance and may not be accurate for individuals in the early stages of Alzheimer's disease. In contrast, the p-Tau217 test examines the accumulation of harmful proteins at a biological level, offering earlier and more precise detection.

2 / I don't have any symptoms. Should I still get tested?

Some brain changes can develop silently for years before symptoms appear. Early testing and detection can provide a critical window for intervention and prevention.

3 / Is this test safe?

Yes, it is completely safe. It involves a routine blood draw,

no different from a standard blood test.

bottom of page